Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation

Song-Hee Kim1, Changseon Na1, Cheng-Yong Yun1,2

  • 1College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.

Insights

Yakuchinone A inhibits skin hyperpigmentation by targeting CREB and CRTCs phosphorylation circuits, crucial for MITF-M expression in melanogenesis. This study reveals Yaku A

Area of Science:

  • Dermatology
  • Molecular Biology
  • Biochemistry

Background:

  • Microphthalmia-associated transcription factor M (MITF-M) regulates melanosome biogenesis and pigmentation in epidermal melanocytes.
  • CREB and CRTCs cooperate in MITF-M transcriptional activation, making their phosphorylation a target for controlling skin pigmentation.

Purpose of the Study:

  • To investigate yakuchinone A (Yaku A) as an inhibitor of facultative melanogenesis.
  • To elucidate the mechanism of Yaku A in targeting CREB and CRTCs phosphorylation circuits for MITF-M expression.

Main Methods:

  • Utilized human epidermal melanocytes, mouse skin, and mouse melanoma cells.
  • Employed Western blotting, RT-PCR, immunoprecipitation, and confocal microscopy.
  • Assessed melanin production and protein phosphorylation levels.

Main Results:

  • α-MSH induced melanogenesis via the PKA-SIKs axis, leading to CRTCs dephosphorylation.
  • Yaku A prevented UV-B-induced skin hyperpigmentation and inhibited melanin production.
  • Yaku A suppressed MITF-M expression by targeting cAMP-dependent PKA activity and CRTCs nuclear import.

Conclusions:

  • Targeting CREB and CRTCs phosphorylation circuits is a viable strategy for preventing skin hyperpigmentation.
  • Yakuchinone A demonstrates potential as a therapeutic agent for pigmentary disorders.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.0K